BioSpace News Archive

The tally is in! After its nationwide August fundraising campaign in Texas de Brazil Churrascarias, a finale charity luncheon at the Dallas location, and a corporate match donation of $25,000, nearly $176,000 was donated by the family-owned Brazilian steakhouse brand to St. Jude Children’s Research Hospital® which is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.

As Commissioner of the U.S. Food and Drug Administration, I remain committed to finding new ways to reduce the burden of chronic disease through improved nutrition

The old approach to cannabis did not work. It let criminals and organized crime profit, while failing to keep cannabis out of the hands of Canadian youth.

The clock’s ticking but there’s still time to apply for one of Edison International’s $40,000 scholarships awarded to high school seniors who want to make a difference in the world through science, technology, engineering or math (STEM) studies.

Benchmark, a leading provider of senior housing in the Northeast, today announced that it has been named by The Boston Globe as one of the Top Places to Work for the 11th straight year.

vTv Therapeutics Inc. today announced that company management will present a corporate overview at the Piper Jaffray 30th Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET in New York City.

Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has named Shig Hamamatsu as senior vice president, chief financial officer effective immediately.

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 cents per common share, an increase of 2.7 percent from the previous quarter.

Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform, today announced that it has commenced its previously announced rights offering of $45,000,000 of its common stock.

Indivior PLC (LON: INDV) today announced that PERSERISTM(risperidone) for extended-release injectable suspension is now available in the United States. PERSERIS is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults.